Abstract
Cf-252 has been shown to be effective as a radium substitute for cancer radiation therapy. Since it is a neutron emitter, it can be used for neutron therapy and has biological advantages for the treatment of bulky, advanced or radioresistant cancers. The greatest advantages have been shown for gynecological, head and neck and body surface or aero-digestive tumors where tumors of large size or known radioresistance are better treated by Cf neutrons than by photon therapy. The greatest potential for Cf-252 (Cf) neutrons may be because the emitted neutrons are of low energy and become thermalized in tumor/ tissue thus making boron neutron capture enhancement (BNCE) of Cf brachytherapy possible. We have carried out studies of BNCE including MCNP computer analysis, direct measurement, treatment planning and experimental animal studies. These studies all support the potential applicability of BNCE for human cancer therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
I. Maruyama, Y. Cf-252 neutron brachytherapy: An advance for bulky localized cancer therapy. Nucl. Sci. Appl. 1: 677–748, 1984.
Maruyama, Y, van Nagell, JR, Yoneda, J et al. A review of californium-252 neutron brachytherapy for cervical cancer. Cancer 68: 1189–1197, 1991.
Maruyama, Y, Beach, JL, Feola, JM. Californium-252 Brachytherapy and Fast Neutron Beam Therapy. Nucl. Sci. Appl. 2: 187–826, 1986.
Locher, GL Biological effects and therapeutic possibilities of neutrons. Am. J. Roent. Radium Ther. 36: 1–13, 1936.
Hatanaka, H. Boron Neutron Capture Therapy for Tumors. Nishimura, Niigata. 1986.
Mishima, Y. Melanoma Neutron Capture Therapy. Alan R. Liss, NY. 1989.
Schroy, CB, Beach, JL, Goud, SN, Feola, JM, Maruyama, Y and Blue, JW. Potential for boron neutron capture enhancement of Cf-252 brachytherapy of localized tumors. Nucl. Sci. Appl. 2: 763–769, 1986.
Beach, JL, Schroy, CB, Ashtari, M, Harris, MR and Maruyama, Y. Boron neutron capture enhancement of 252Cf brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 18: 1421–1427, 1990.
Wierzbicki, JG, Maruyama, Y, and Porter, AT. Measurement of augmentation of 252Cf by 10B and 157Gd. Medical Phys. 21: 787–790, 1994.
Yanch, JC, Zamenhof, RG, Wierzbicki, JG and Maruyama, Y. Comparison of dose distributions with 10Boron augmented sources of 2252Cf obtained by Monte Carlo simulation and by experimental measurement. In, Progress in Neutron Capture Therapy for Cancer. Allen, BJ et al. (Eds). Plenum Press, NY. pp. 191–194, 1992.
Matalka, KZ, Barth, RF, Bailey, MQ, Maruyama, Y, Feola, JM and Wierzbicki, J. Californium-252 brachytherapy of intracerebral melanoma with and without administration of boronophenylalanine utilizing a nude rat model. In, Advances in Neutron Capture Therapy. Soloway, AH et al. Plenum, NY. pp. 529–533, 1993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maruyama, Y., Mesina, C., Wierzbicki, J., Porter, A.T. (1996). Clinical Californium-252 Boron Neutron Capture Enhancement. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_124
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_124
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive